Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;35(10):2899-2900.
doi: 10.1038/s41433-020-01211-4. Epub 2020 Sep 30.

Pre-filled aflibercept syringes-variability in expressed fluid volumes and a case series of transient central retinal artery occlusions

Kevin Gallagher  1 , A R Raghuram  2 , Gwyn Samuel Williams  3 , Nigel Davies  4
Affiliations

Pre-filled aflibercept syringes-variability in expressed fluid volumes and a case series of transient central retinal artery occlusions

Kevin Gallagher et al. Eye (Lond). 2021 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Box plot showing greater variability of expressed volumes with PFS vs 1 ml syringe.
Box plot comparing pre-filled aflibercept syringe with standard 1 ml syringe.
See this image and copyright information in PMC

References

    1. Pallikaris I, Kymionis G, Ginis H, Kounis G, Tsilimbaris M. Ocular rigidity in living human eyes. Investig Ophthalmol Vis Sci. 2005;46:409–14. doi: 10.1167/iovs.04-0162. - DOI - PubMed
    1. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. D’Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET, Jr, Guyer DR, et al. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology. 2006;113:992–1001.e6. doi: 10.1016/j.ophtha.2006.02.027. - DOI - PubMed

Substances